# Update on Reproxalap PDUFA Timing

Page: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing
Text version: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing.md
Podcast: [Eyewire News: The Podcast](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536)
Published: 2025-12-17T20:44:00+00:00
Episode link: https://traffic.megaphone.fm/BMCL3681770584.mp3
Audio file: https://traffic.megaphone.fm/BMCL3681770584.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/update-on-reproxalap-pdufa-timing
Duration seconds: 531

## Resource

Aldeyra provides an update on the timing of its dry eye disease treatment candidate reproxalap; Ocular Therapeutix pursues an accelerated NDA pathway for wet AMD therapy Axpaxli; and companies with late-stage drug candidates announce FDA submission plans. Learn more about your ad choices. Visit megaphone.fm/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/update-on-reproxalap-pdufa-timing/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.